ArticleBMC immunology2024

GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy.

Hae-Mi Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.